Scarica l'app Stockscreener
61.73
1.68%
0.9267
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$60.80
Aprire:
$60.87
Volume 24 ore:
143.55K
Relative Volume:
0.06
Capitalizzazione di mercato:
$13.99B
Reddito:
$4.03B
Utile/perdita netta:
$789.50M
Rapporto P/E:
18.54
EPS:
3.33
Flusso di cassa netto:
$1.15B
1 W Prestazione:
+0.57%
1M Prestazione:
-3.94%
6M Prestazione:
-22.82%
1 anno Prestazione:
-18.84%
Intervallo 1D:
$60.54
$61.88
Intervallo di 1 settimana:
$60.36
$62.12
Portata 52W:
$60.34
$84.67
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Confronta HOLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
61.73 | 13.99B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
515.36 | 182.21B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
229.66 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.45 | 45.01B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
224.02 | 32.73B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
225.08 | 16.82B | 2.88B | 499.60M | 321.60M | 6.74 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-03 | Downgrade | Argus | Buy → Hold |
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
Hologic Stock: Is HOLX Underperforming the Healthcare Sector? - Nasdaq
Press Release Service: United States Molecular Diagnostics Market Forecast Report and Company Analysis 2025-2033 Featuring F Hoffmann-la Roche, Illumina, Hologic, Agilent, Qiagen, Myriad Genetics, Abbott, Danaher, BD & CoResearchAndMarkets.co - CRISPR Medicine News
Analysis of China's $1.13 Billion Biopsy Devices Market, - GlobeNewswire
Analysis of China's $1.13 Billion Biopsy Devices Market, 2025-2033: Cardinal Health, Hologic, and Danaher Corporation Lead the Competition - Yahoo Finance
Hologic (HOLX) Advances But Underperforms Market: Key Facts - Yahoo Finance
Investing in Hologic (NASDAQ:HOLX) five years ago would have delivered you a 76% gain - Yahoo Finance
Molecular Diagnostics Market Is Booming Worldwide 2025-2032 | - openPR
Biopsy Devices Market Generated Opportunities, Future Scope - openPR
Breast Biopsy Devices Market Is Booming Worldwide 2025-2032 | - openPR
New Product Launches to Support HOLX Stock Amid Macro Issues - MSN
Liposuction Surgery Devices Market Growth Report and - GlobeNewswire
Liposuction Surgery Devices Market Growth Report and Company Analysis 2025-2033 Featuring SOLTA MEDICAL, InMode, Genesis Biosystems, Hologic, Apyx Medical, Cynosure, YOLO Medical, and Sciton - Yahoo Finance
Mammography Market is projected to witness lucrative growth - openPR
HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip? - Yahoo Finance
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know - Yahoo Finance
Redburn Atlantic Adjusts Hologic Price Target to $72 From $82, Keeps Neutral Rating -March 18, 2025 at 12:32 pm EDT - Marketscreener.com
Gynecological Devices Market 2025-2032 is Thriving Worldwide - openPR
Hologic (HOLX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
In Vitro Diagnostics Market reached US$ 84.90 billion in 2024 - openPR
Ultrasound Market Industry Report 2025, with Focus on Key Players CHISON Medical Technologies, Clarius, Draminski, Esaote, GE HealthCare, Hologic, Promed Technology, SIUI, SonoScape & more - Yahoo Finance
Transplantation Market Growth | Trends, Opportunities & Global Forecast 2024-2031 | Hologic, Inc, QIAGEN, XVIVO. - openPR
Fluoroscopy and C-Arm Market Growth in Future Scope 2025-2032 | - openPR
Hologic stock hits 52-week low at $61.67 amid market shifts - Investing.com Australia
Hologic stock hits 52-week low at $61.67 amid market shifts By Investing.com - Investing.com South Africa
Fluoroscopy Devices Market Set to Expand Due to Rising Demand - openPR
Clinical Diagnostic Market Set for Strong Growth | Advanced - openPR
Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued? - Simply Wall St
Breast Cancer Screening Market to Hit $11.7 Billion by 2033Key - openPR
Molecular Diagnostics Market Business Opportunities - openPR
Cancer Diagnostics Market Top PlayersGE Healthcare, Abbott - openPR
BioZorb Lawuit LawyerBreast Biopsy Marker RecallMarch 2025 Update - Levin Papantonio
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Mutual of America Capital Management LLC - Defense World
Why Is Hologic (HOLX) Down 4.5% Since Last Earnings Report? - Yahoo Finance
Lumos expands development deal with Hologic for premature birth test - MSN
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - Yahoo Finance Australia
Cosmetic Surgery Market Forecast Report and Company - GlobeNewswire
Cosmetic Surgery Market Forecast Report and Company Analysis 2025-2033 Featuring AbbVie, Cutera, Sientra, Bausch Health, Johnson & Johnson, Apyx Medical, Hologic, Merz Pharma, Galderma, Cynosure - Yahoo Finance
Hologic, Inc. (NASDAQ:HOLX) Receives Consensus Rating of “Hold” from Brokerages - Defense World
Mammography Machine Market Expands: $2.6 Bn in 2024 to $4.1 Bn - openPR
X-ray Machine Manufacturing Market to Witness Remarkable - openPR
Digital X-ray Devices Market to Witness Remarkable Growth with Hologic, Inc., Hitachi, Ltd., Siemens Healthineers - openPR
Hologic (NASDAQ:HOLX) Price Target Cut to $70.00 by Analysts at Citigroup - Defense World
Fluoroscopy Devices Market Projected To Witness Massive - openPR
Hologic (NASDAQ:HOLX) Sets New 1-Year Low After Analyst Downgrade - Defense World
Hologic stock touches 52-week low at $62.67 amid market shifts - Investing.com Canada
Breast Cancer Brachytherapy Market Future Business - openPR
11 Analysts Have This To Say About Hologic - Benzinga
Hologic cut to Hold at Argus amid slower mammography equipment sales - Yahoo Finance
Lumos expands deal for premmie birth test - NT News
Citigroup Adjusts Price Target on Hologic to $70 From $80, Maintains Neutral Rating -March 04, 2025 at 06:07 am EST - Marketscreener.com
Breast Cancer Diagnostic Market Projected To Witness Massive - openPR
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.88%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):